LYCOS RETRIEVER 
Arthritis Treatment
built 807 days ago
Joan Bathon, M.D., of the Division of Rheumatology, Department of Medicine, Johns Hopkins University, has written extensively about the treatment of rheumatoid arthritis and the treatment available at Johns Hopkins Medicine. For more information, please visit the Johns Hopkins Arthritis web site.
Source:
A plant found in central southern Africa called Devil's Claw (left) has been found remarkably effective as an arthritis treatment. In a number of trials conducted in Germany and France over the last two decades, it has been shown to be effective. The dried and powdered tubers are used; their action appears to be both detoxifying and stimulating to the body's own immune system. No harmful effects have shown up, even in high doses. (CAUTION: Diabetics should warn their doctors if they are taking Devil's Claw: it can significantly lower insulin requirements). Devil's Claw can be bought in the form of tea, tablets, or in a tincture made from the fresh plant, called Harpagophytum procumbeus, by Bioforce.
Source:
There was an article in the Autumn 1998 issue of Vegetarian Dietetics on "Vegetarian Diets in the Treatment of Rheumatoid Arthritis" that might be of interest to you. It is accessible online at http://www.andrews.edu/NUFS/arthritis.html.
Source:
If possible, treatment will focus on eliminating the underlying cause of the arthritis. However, the cause is NOT necessarily curable, as with osteoarthritis and rheumatoid arthritis. Treatment, therefore, aims at reducing your pain and discomfort and preventing further disability.
Source:
Long-term medical care with regularly scheduled visits is essential for the successful treatment of rheumatoid arthritis. This care often entails medical visits and tests every three to five weeks to assess the effectiveness of treatment and monitor for side effects.
Source:
Abatacept is the only costimulation modulator currently available to treat rheumatoid arthritis in the United States. People with moderate to severe rheumatoid arthritis who haven't adequately benefited from methotrexate or tumor necrosis factor-alpha (TNF-alpha) inhibitors, including adalimumab (Humira), etanercept (Enbrel) and infliximab (Remicade), can consider abatacept.
Source:
MORE ABOUT
Arthritis Treatment